Patni Rajiv — SEC Form 4 filings

SEC reporting owner CIK 1616200. 6 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-02-15 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Quince Therapeutics, Inc. (QNCX)Director33
BioXcel Therapeutics, Inc. (BTAI)Director22
Septerna, Inc. (SEPN)Chief Medical Officer11

Form 4 filings — Patni Rajiv

FiledFormIssuerReported transactionsSource
2026-09-104Septerna, Inc. (SEPN)Grant/award (A): 275,000 (derivative) @ $0EDGAR
2026-01-124BioXcel Therapeutics, Inc. (BTAI)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2025-06-064Quince Therapeutics, Inc. (QNCX)Grant/award (A): 27,000 (derivative) @ $0EDGAR
2025-01-164BioXcel Therapeutics, Inc. (BTAI)Grant/award (A): 44,000 (derivative) @ $0EDGAR
2024-06-074Quince Therapeutics, Inc. (QNCX)Grant/award (A): 13,500 (derivative) @ $0EDGAR
2024-02-154Quince Therapeutics, Inc. (QNCX)Grant/award (A): 54,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1616200 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →